TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 0 | -3 | -9 | 0 | 0 | 0 | -6 |
| P | %wins | 100 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/1/20 16:57 | 11/30/20 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vounatsos Michel | MA | DO | CEO | P | 748 | 241.31 | 0 | 3 | 10 | 35 | D | ||||||||||||||
5/2/19 16:30 | 5/1/19 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vounatsos Michel | MA | DO | CEO | P | 1,007 | 231.48 | 0 | 4 | 26 | 21 | D | ||||||||||||||
1/2/18 16:21 | 12/29/17 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vounatsos Michel | MA | DO | CEO | P | 250 | 320.55 | 0 | 1 | 19 | 5 | D | ||||||||||||||
5/2/17 16:18 | 5/1/17 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vounatsos Michel | MA | DO | CEO | P | 380 | 271.35 | 33 | 1 | 92 | 3 | D | -28 | -1 | -7 | -2 | -1 | 1 | -1 | -3 | 0 | -4 | ||||
3/1/17 16:18 | 2/27/17 | BIIB | Biogen Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Vounatsos Michel | MA | DO | CEO | P | 380 | 285.39 | 33 | 1 | 999% | 1 | D | -30 | 11 | -6 | -5 | 2 | 8 | -1 | 1 | 0 | -1 | -9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |